Publikation

  • Metastatic Esophagogastric Adenocarcinoma: Trends in First-Line Treatment and Predictive Factors for the Implementation of HER2 Testing in Clinical Practice During the First Year after Trastuzumab Market Approval
    Deniz Gencer, Salah-Eddin Al-Batran, Reyad Dada, Ali-Nuri Hünerlitürkoglu,,Michael Gonnermann, Thomas Kegel, Harald Scheiber, Wolf-Oliver Jordan, Iris Burkholder, Lenka Kellermann, Ralf-Dieter Hofheinz. --> PDF